CD8A and rheumatoid arthritis: Notably, senescent CD4+ and CD8+ T cells have been implicated in the pathologic bone loss observed in osteolytic diseases, such as RA, juvenile idiopathic arthritis and Ankylosing Spondylitis (AS) [86,87].